Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 321 Million | USD 484 Million | 5% | 2023 |
The U.S. alginate dressings market size was evaluated at $321 million in 2023 and is slated to hit $484 million by the end of 2032 with a CAGR of nearly 5% between 2024 and 2032.
Alginate dressings are specialized wound care items made from alginate, a natural polysaccharide extracted from brown seaweed. Reportedly, these dressings have gained huge significance in the medical sector owing to their exceptional features and effectiveness in healing various kinds of wounds. Beneficial features such as high absorbency, biocompatibility, gel formation, and hemostatic characteristics have enhanced their use in the healthcare sector.
An increase in chronic wounds caused due to accidents can propel the market growth in the U.S.
A surge in the cases of chronic wounds due to road collisions along with a lack of healing of wounds in rapidly rising diabetics can prop up the growth of the U.S. alginate dressings market. An increase in the geriatric populace and a rise in the number of surgical procedures will proliferate the market space in the country. Breakthroughs in the wound care technology and acceptance of new wound care items will prompt the growth of the market in the U.S. Rapidly expanding healthcare amenities along with the flourishing home healthcare sector is anticipated to spur the growth of the market in the country. Moreover, an increase in construction activities with a surging population in the country has resulted in accidents of workers during construction, thereby paving the way for huge growth of the market in the country.
Rise in product prices can retard the industry growth in the country over 2024-2032
Surging prices of alginate dressings in comparison to other kinds of wound dressings and inadequate compensation policies can deter the growth of the U.S. alginate dressings industry. Lack of awareness about product benefits among healthcare service providers can further impede the expansion of the industry in the country.
An increase in the number of diabetics prone to foot ulcers can open new growth avenues for the market in the U.S.
A surge in the cases of chronic wounds including diabetic foot ulcers requiring a high proportion of absorbency and a need for effectively curing them is likely to open new growth avenues for the U.S alginate dressings market. Rapidly expanding healthcare amenities such as wound care units and clinics can proliferate the growth of the market in the country.
Oscillations witnessed in supply chain activities & strict regulations over product approval in the U.S. can challenge the industry growth
Supply chain disruptions and challenges involved in receiving approval for the products from the U.S. government can obstruct the growth of the U.S. alginate dressings industry. Easy availability of substitute products including hydrocolloids and films at inexpensive prices can challenge the growth of the industry in the country.
The U.S. alginate dressings market is divided into type, application, end-use, and region.
In terms of type, the U.S. alginate dressings market across the globe is bifurcated into non-antimicrobial and antimicrobial segments. Additionally, the antimicrobial segment, which accumulated about half of the market share in 2023, is predicted to register the fastest gains during the period from 2024 to 2032 subject to the ability of the alginate dressings of antimicrobial kind to arrest the microbe proliferation in the wounds. Reportedly, surging demand for the product owing to its beneficial features such as infection control and chronic wound management will drive the segmental space in the coming years
Based on the application, the U.S. alginate dressings industry is divided into acute wounds, diabetic foot ulcers, surgical & traumatic wounds, pressure ulcers, burns, and venous leg ulcers segments. Additionally, the diabetic foot ulcers segment, which accrued a large portion of the industry revenue in 2023, is set to make major contributions towards the industry share in the U.S. during the forecasting timeline owing to the ability of alginate dressings in absorbing exudate in diabetic foot ulcers in patients. In addition to this, an increase in the number of diabetics in the country suffering from diabetic foot ulcers has resulted in the launching of new kinds of alginate dressings for treating these ulcers.
On the basis of end-use, the U.S. alginate dressings market is sectored into hospitals, home healthcare, and specialty clinics segments. Moreover, the hospital segment, which gathered a high percentage of industry size in 2023, is anticipated to spearhead the expansion of the segment in the coming years owing to an increment in the use of alginate dressings in U.S. hospitals for addressing wound issues. Apart from this, a rise in the hospital admissions of the elderly population prone to suffer from diabetic ulcers can further augment the growth of the segment in the coming years. Easy access to specialized wound management in hospital settings will provide impetus to the use of alginate dressings in hospitals.
Report Attributes | Report Details |
---|---|
Report Name | U.S. Alginate Dressings Market |
Market Size in 2023 | USD 321 Million |
Market Forecast in 2032 | USD 484 Million |
Growth Rate | CAGR of 5% |
Number of Pages | 226 |
Key Companies Covered | Derma Sciences Inc., The 3M Company, Integra LifeSciences Corporation, Smith & Nephew plc, Advanced Medical Solutions Group plc, Acelity L.P. Inc., BSN medical GmbH, Coloplast A/S, Lohmann & Rauscher International GmbH & Co. KG, Hollister Incorporated, Johnson & Johnson Services Inc., Medtronic plc, ConvaTec Group plc, Medline Industries Inc., Mölnlycke Health Care AB., and others. |
Segments Covered | By Type, By Application, By End-Use, and By Region |
Regions Covered in U.S. | Northeast, Midwest, South, and West |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Northeast region of the U.S. is expected to dominate the U.S. alginate dressings market growth over 2024-2032
The northeastern region, which contributed nearly 59% of the U.S. alginate dressings market share in 2023, is projected to establish a strong position in the U.S. market in the years to come. In addition to this, the regional market expansion in the forecast timespan can be credited to a rise in chronic wound cases in the region along with technological breakthroughs in the wound care sector. An increase in the elderly population prone to chronic wounds can offer new growth avenues for the market in the region.
Southern alginate dressings industry is predicted to register the highest rate of growth annually in the coming few years. The expansion of the industry in the region can be due to the large-scale presence of key players in the region. Additionally, the availability of strong healthcare infrastructure and the allocation of high budgets to the healthcare sector will prop up the growth of the market in the region.
The U.S. alginate dressings market profiles key players such as:
By Type
By Application
By End-Use
The U.S.
FrequentlyAsked Questions
Alginate dressings are specialized wound care items that are made from alginate, a natural polysaccharide extracted from brown seaweed.
The global U.S. alginate dressings market growth over the forecast period can be owing to breakthroughs in wound care technology and acceptance of new wound care items.
According to a study, the global U.S. alginate dressings industry size was $321 million in 2023 and is projected to reach $484 million by the end of 2032.
The global U.S. alginate dressings market is anticipated to record a CAGR of nearly 5% from 2024 to 2032.
The U.S. alginate dressings market is led by players such as Derma Sciences Inc., The 3M Company, Integra LifeSciences Corporation, Smith & Nephew plc, Advanced Medical Solutions Group plc, Acelity L.P. Inc., BSN medical GmbH, Coloplast A/S, Lohmann & Rauscher International GmbH & Co. KG, Hollister Incorporated, Johnson & Johnson Services Inc., Medtronic plc, ConvaTec Group plc, Medline Industries Inc., and Mölnlycke Health Care AB.
The U.S. alginate dressings market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed